文献速递肺外科

单孔胸腔镜与开胸支气管袖式切除加肺动脉成形术治疗中心型非小细胞肺癌的比较

Comparison of uniportal video-assisted thoracoscopic versus thoracotomy bronchial sleeve lobectomy with pulmonary arterioplasty for centrally located non-small-cell lung cancer.
PubMed 文献 · Eur J Cardiothorac Surg · 2021-01-01

UniVATS组术后输血率更低、住院时间更短、引流时间更短且术后24小时引流量更少,而3年总生存和无复发生存两组相当。结论认为在合适患者选择和丰富胸腔镜经验的胸外科医生手中,UniVATS袖式切除加肺动脉成形术可行且安全。

要点

  • UniVATS组术后输血率、住院时间和引流时间均优于开胸组。
  • 两组3年总生存和无复发生存无显著差异。
  • 鳞癌是总生存的独立有利预测因素,晚期病理分期与更差生存独立相关。

核心结论

  • 在合适患者选择和丰富胸腔镜经验的胸外科医生手中,UniVATS支气管袖式切除加肺动脉成形术治疗中心型肺癌可行且安全。

主要发现

  • 与开胸组相比,UniVATS组术后输血率更低(P = 0.043)。
  • UniVATS组术后住院时间更短(P = 0.008)。
  • UniVATS组引流时间更短(P = 0.003),术后第一个24小时引流量更少(P = 0.005)。
  • 两组3年总生存(log-rank P = 0.81)和无复发生存(log-rank P = 0.78)相当。
  • 鳞癌是总生存的独立有利预测因素(HR 0.44,95%CI 0.24-0.80;P = 0.008),IIIB期与更差总生存(HR 3.21,95%CI 1.13-9.12;P = 0.028)和无复发生存(HR 3.54,95%CI 1.32-9.51;P = 0.012)独立相关。

临床怎么用

  • 对于中心型非小细胞肺癌,在积累丰富胸腔镜经验的胸外科医生手中,可考虑对合适患者选择UniVATS支气管袖式切除加肺动脉成形术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aimed to investigate the efficacy of bronchial sleeve lobectomy with pulmonary arterioplasty by uniportal video-assisted thoracoscopic surgery (UniVATS) in centrally located non-small-cell lung cancer. METHODS: One hundred and two thoracotomy and 31 UniVATS cases were included in this retrospective, single-centre study. Baseline characteristics, perioperative performance and survival outcomes were compared between the 2 groups. RESULTS: Compared with the thoracotomy group, the UniVATS group was associated with lower postoperative blood transfusion rate (P = 0.043), decreased postoperative hospital stays (P = 0.008), shorter drainage duration (P = 0.003) and less drainage volume during the first postoperative 24 h (P = 0.005). Besides, the 3-year overall survival and recurrence-free survival were comparable between the 2 groups (log-rank, P = 0.81 and P = 0.78, respectively). In addition, squamous cell carcinoma was proved to be the independent favourable predictor for overall survival [hazard ratio (HR) 0.44, 95% confidence interval (CI) 0.24-0.80; P = 0.008], and advanced pathological stage was found to be independently associated with worse overall survival (IIIB stage: HR 3.21, 95% CI 1.13-9.12; P = 0.028) and recurrence-free survival (IIIB stage: HR 3.54, 95% CI 1.32-9.51; P = 0.012). CONCLUSIONS: With appropriate patient selection, UniVATS sleeve lobectomy with pulmonary arterioplasty is feasible and safe for centrally located lung cancer in the hands of thoracic surgeons with extensive thoracoscopy experience.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Xie D, Zhong Y, Deng J, et al. Comparison of uniportal video-assisted thoracoscopic versus thoracotomy bronchial sleeve lobectomy with pulmonary arterioplasty for centrally located non-small-cell lung cancer. Eur J Cardiothorac Surg. 2021. PMID: 33966071. doi:10.1093/ejcts/ezaa404

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。